Kwality Pharmaceuticals Ltd (BSE: 539997) is a Amritsar, Punjab-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹3,665 Cr, it ranks #950 by market cap among the 6,189 Indian listed companies on FinBizNet, and #31 of 86 in Medicinal Chemicals and Botanical Products. At ₹3,531.70 (as of 26 Oct 2026), the share price is 10.6% below its 52-week high of ₹3,949.00 and 12.6% above its 52-week low of ₹3,137.00.
| Current Price | ₹3,531.70 |
|---|---|
| Market Cap | ₹3,665 Cr |
| BSE Code | 539997 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 54.4 |
| Return on Equity | 22.74% |
| Return on Assets | 12.08% |
| 52-Week Range | ₹3,137.00 – ₹3,949.00 |
| 3-Month Price Change | +66.4% |
| Beta (1Y) | 1.14 |
| Dividend Yield | 0.00% |
| Headquarters | Amritsar, Punjab |
| Website | www.kwalitypharma.com |
| Revenue | ₹162 Cr |
|---|---|
| Net Profit | ₹26 Cr |
| Net Margin | 15.8% |
| EPS (Basic) | ₹24.70 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally. The company offers its products in various dosage forms, including liquid orals, powder for oral suspension, dry syrups, tablets, capsules, sterile powder for injections, small volume parentals (liquid and lyophilized), pre filled syringes, ointments and creams, ophthalmic preparations, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized products, syrups, daunorubicin, and various other categories such as general, beta-lactam, cephalosporins, cytotoxic (oncology), and biological. It also provides intermediates, chemicals, extracts, alkaloids, toilet requisites, beverages, and other medical preparations. Kwality Pharmaceuticals Limited was incorporated in 1983 and is based in Amritsar, India.
1. Pharmaceuticals-This segment engages in manufacturing of a range of finished pharmaceutical formulations in a dosage forms, such as tablets, capsules, syrup, dry syrup, injections etc.
1. Pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,19,404 Cr | 36.6 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,658 Cr | 22.5 | 18.32% | ₹8,017 Cr | +14.7% |
| Cipla Limited | ₹1,08,090 Cr | 27.9 | 11.74% | ₹7,119 Cr | -14.7% |
| Laurus Labs Ltd | ₹1,06,442 Cr | 119.8 | 17.74% | ₹2,026 Cr | +125.7% |
| Dr.Reddys Lab | ₹1,02,010 Cr | 23.8 | 11.52% | ₹8,698 Cr | -0.9% |
| Mankind Pharma | ₹91,379 Cr | 47.8 | 12.45% | ₹4,031 Cr | -9.9% |
| Aurobindo Pharma Ltd. | ₹90,432 Cr | 26 | 9.93% | ₹9,150 Cr | +41.7% |
| Lupin Ltd | ₹88,018 Cr | 16.5 | 26.91% | ₹8,277 Cr | -1.1% |
| Kwality Pharmaceuticals Ltd | ₹3,665 Cr | 54.4 | 22.74% | ₹162 Cr | — |
Listed by market capitalisation. Ratios are shown for context only.
Kwality Pharmaceuticals Ltd is trading at ₹3,531.70, with a market capitalisation of ₹3,665 Cr.
Kwality Pharmaceuticals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Kwality Pharmaceuticals Ltd has a P/E of 54.4 and a return on equity of 22.74%.
Kwality Pharmaceuticals Ltd is listed on the BSE under the scrip code 539997.
In Q1 FY27, Kwality Pharmaceuticals Ltd reported revenue of ₹162 Cr and net profit of ₹26 Cr, with basic EPS of ₹24.7 (standalone, parsed from the company's exchange filing).
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.